Studies have shown that the NAPRT gene, the second NAD+ production enzyme, is amplified and overexpressed in cancers, and the combined inhibition of NAMPT and NAPRT may help improve drug resistance in tumors [112]. This evidence concerns the gene NAMPT and cancer.